Document is current
Any future updates will be listed below
-
Authors
Garcia-Alvarez, Alejandro http://orcid.org/0000-0001-6948-0485
Hernando Cubero, Jorge
Capdevila, Jaume
- License Information
-
More Information
Article History
Accepted: 18 February 2021
First Online: 30 March 2021
Compliance with Ethical Standards
:
: Alejandro Garcia-Alvarez declares that he has no conflict of interest.Jorge Hernandro Cubero has received compensation for service on speakers' bureaus from Eisai, Ipsen, Novartis, Roche, Pfizer, Angelini Pharma, and Advanced Accelerator Applications.Jaume Capdevila has received research funding from Eisai, AstraZeneca, Advanced Accelerator Applications, Ipsen, Pfizer, and Novartis; has received compensation from Bayer, Eisai, Advanced Accelerator Applications, Ipsen, Pfizer, Merck Serono, Sanofi, Amgen, and Novartis for service as a consultant/guest lecturer.
